Appetite support
Reduced hunger can make it easier to eat smaller portions. Response varies, and treatment can also cause side effects.
Illustrative packaging. Final product may differ.
GLP-1 options
Tirzepatide without B12
GLP-1 / GIP receptor agonist
Less hunger can make a difference. Explore how tirzepatide works on two appetite pathways and discuss your options with a clinician.
Order online, subject to clinical review
Uses & evidence at a glance
- Tirzepatide acts on two hormone pathways involved in appetite and blood sugar.
- Approved products support weight management; compounded formulations are not FDA-approved.
For prescribed peptide self-injection only, not Botox or IVs. Take your first dose with Christina’s guidance and learn to continue at home, when clinically appropriate. NYC appointments are priced and scheduled separately. No training fee is charged at checkout.
Meet Christina and explore training →Payment requests an initial order. Clinical approval is required before fulfillment.
Read the evidence for Tirzepatide ↗THE PLAIN-LANGUAGE GUIDE
What does tirzepatide do?
Tirzepatide acts on two hormone receptors, GIP and GLP-1, involved in appetite and food intake. In simple terms, the goal is less hunger and support with eating less.
The benefits below describe the active ingredient in FDA-approved Zepbound. This catalog option is compounded and is not FDA-approved; the same results cannot be assumed.
Weight-management goals
Zepbound is used alongside reduced-calorie eating and physical activity to help eligible people lose weight and maintain that loss.
A plan with clinical support
People consider treatment when they want help with weight management. A clinician reviews suitability, formulation, dose, and follow-up rather than promising a particular result.
Evidence: Zepbound uses and safety information. For a side-by-side explanation, read semaglutide vs. tirzepatide.
What does “Non-B12 additive” mean?
This catalog label distinguishes the option from the B12-added formulation. Confirm the exact ingredients and concentration with the prescribing clinician and dispensing pharmacy.
Understand compounded formulations, B12, and microdosing →Side effects and suitability: what to discuss
Common side effects include nausea, vomiting, diarrhea, and constipation. Serious risks can include pancreatitis and gallbladder problems. Approved products carry a thyroid-tumor warning and are contraindicated with a personal or family history of medullary thyroid cancer or MEN 2.
Discuss pregnancy plans, medical history, and all medicines with your clinician. Do not combine semaglutide and tirzepatide. This is a summary, not complete prescribing information.
Compounded drugs have not been reviewed by FDA for safety, effectiveness, or quality. They should only be used when a patient's medical needs cannot be met by an approved drug. Read FDA’s compounded GLP-1 guidance.
DIVE DEEPER
Compare your options. Understand the details.
Metabolic health
Semaglutide vs tirzepatide: what actually differs?
Compare how they work, weight-loss trial results, safety considerations, and the distinction between approved and compounded products.
Read the guide Understanding formulationsCompounded GLP-1s, B12, and microdosing: a clearer guide
Understand B12 additives, non-B12 formulations, and microdose labels before discussing a compounded GLP-1 with a clinician.
Read the guide Weight-loss eligibilityWho qualifies for GLP-1 weight-loss treatment?
Learn how clinicians assess GLP-1 weight-loss eligibility, why BMI is only a starting point, and what to ask before medical intake. Includes NIH and FDA sources.
Read the guide Pricing explainedHow to compare the full cost of weight-loss treatment
Compare medication prices, clinical review, shipping, supply length, and refill terms. Use a simple worksheet to understand costs before choosing a program.
Read the guideAN INFORMED NEXT STEP
Start with understanding.
Look at the evidence for the exact formulation and intended use before making a decision.
- Explore the evidence. Read the guide below, including the limits of current research.
- Know the full details. Confirm formulation, availability in your state, and the complete cost.
- Discuss with a clinician. Review your goals and medical history before any treatment decision.
BEFORE YOU DECIDE
Common questions.
What does Tirzepatide (Non-B12 additive) do?
Less hunger can make a difference. Explore how tirzepatide works on two appetite pathways and discuss your options with a clinician. Tirzepatide acts on two hormone pathways involved in appetite and blood sugar. Approved products support weight management; compounded formulations are not FDA-approved.
Can I order Tirzepatide (Non-B12 additive) through Toven now?
Yes. Add an available product to your cart, choose your purchase option, and complete secure online payment. After payment, we email your secure medical-intake link. A licensed clinician reviews your history before treatment can be approved and the pharmacy can fulfill your order. Payment does not guarantee a prescription. If treatment is declined, your Toven product payment and shipping charge are refunded under our order policy.
What will it cost?
The one-time product price is $229. Eligible subscriptions offer lower product prices. Free standard shipping applies to orders of $300 or more after discounts. Standard shipping is $30 below $300. The doctor’s prescription review fee is $20, paid separately to the clinical provider during medical intake. Any additional clinical or renewal fees will be disclosed before payment. Payment is collected at checkout for the initial requested order, subject to clinical approval.
How do I know if it is appropriate for me?
A licensed clinician must assess your health history, current medications, and treatment goals. A quiz result or catalog listing cannot establish suitability. Do not combine options based on this catalog.
Educational information, not personal medical advice. Compounded medications are not FDA-approved. A catalog listing does not establish safety, effectiveness, or availability. Formulation, location, pharmacy requirements, and independent clinical review determine access.